PAR 2.50% 20.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 585 Posts.
    lightbulb Created with Sketch. 64
    ha ha - quite possible, but wont be for long!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.